Amarin Corporation plc - Special Call Transcript
Welcome to Amarin Corporation's National Lipid Association Scientific Sessions 2020 Late-Breakers Discussion, where select scientific publications presented over the weekend will be discussed. This conference call is being recorded today, December 14, 2020.
I will now turn the conference call over to Alina Kolomeyer, Director of Communications at Amarin.
Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT presented to the medical community at the National Lipid Association Scientific Sessions 2020.
We are honored today to be able to bring to you for your consideration the opinions of an esteemed group of clinicians and scientists. Opinions expressed by the clinicians and scientists on this webcast are theirs alone. They have neither been scripted nor previewed by Amarin. While Amarin values their perspective, we may not necessarily
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |